Kymab kymab.com


Public list: BIO 2016 (619) Pharma Startups (4729) Cancer Therapeutics (1132)

Kymab is committed, with the support of its primary investor, to collaborate with leading academic experts. Kymab Access is a programme that enables academic researchers to pursue the discovery and development of novel human monoclonal antibody therapeutics or vaccines by partnering researchers with Kymab and its Kymouse antibody. Kymab Access is administered by Kymab Access Limited, which is a wholly owned subsidiary of Kymab established solely for this purpose with a confidentiality firewall b...Show all

Kymab is committed, with the support of its primary investor, to collaborate with leading academic experts. Kymab Access is a programme that enables academic researchers to pursue the discovery and development of novel human monoclonal antibody thera...Show all

Company (Alive / Active)

Phone: +44 (0)1223 833301

Fax:

Babraham Research Campus

Cambridge, CB22 3AT
England, United Kingdom

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Kymab $199M Jan 10, 2017

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Kymab Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 6 investors

Board Members

There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Animal models and therapeutic molecules Feb 08, 2016 Mar 27, 2018 Patent
Precision medicine for cholesterol treatment Jul 15, 2014 Mar 13, 2018 Patent
Animal models and therapeutic molecules Apr 11, 2016 Feb 20, 2018 Patent
Synergistic combinations of ox40l antibodies for the treatment of gvhd Jul 27, 2017 Jan 16, 2018 Patent
Synergistic combinations of ox40l antibodies for the treatment of gvhd May 24, 2017 Jan 16, 2018 Patent
See all 105 patents